IDEXX LABORATORIES INC (IX1.DE) Stock Price & Overview
FRA:IX1 • US45168D1046
Current stock price
The current stock price of IX1.DE is 514.6 EUR. Today IX1.DE is down by -8.37%. In the past month the price decreased by -16.57%. In the past year, price increased by 26.97%.
IX1.DE Key Statistics
- Market Cap
- 40.972B
- P/E
- 45.18
- Fwd P/E
- 39.84
- EPS (TTM)
- 11.39
- Dividend Yield
- N/A
IX1.DE Stock Performance
IX1.DE Stock Chart
IX1.DE Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to IX1.DE. When comparing the yearly performance of all stocks, IX1.DE is one of the better performing stocks in the market, outperforming 89.57% of all stocks.
IX1.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to IX1.DE. IX1.DE scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
IX1.DE Earnings
On February 2, 2026 IX1.DE reported an EPS of 3.08 and a revenue of 1.09B. The company beat EPS expectations (3.12% surprise) and missed revenue expectations (-0.31% surprise).
IX1.DE Forecast & Estimates
22 analysts have analysed IX1.DE and the average price target is 692.16 EUR. This implies a price increase of 34.5% is expected in the next year compared to the current price of 514.6.
For the next year, analysts expect an EPS growth of 13.42% and a revenue growth 9.13% for IX1.DE
IX1.DE Groups
Sector & Classification
IX1.DE Financial Highlights
Over the last trailing twelve months IX1.DE reported a non-GAAP Earnings per Share(EPS) of 11.39. The EPS increased by 16.18% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 24.62% | ||
| ROA | 31.62% | ||
| ROE | 65.99% | ||
| Debt/Equity | 0.48 |
IX1.DE Ownership
IX1.DE Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 1MDT | MEDTRONIC PLC | 14.49 | 100.151B | ||
| 2M6 | MEDTRONIC PLC | 14.3 | 98.217B | ||
| SHL | SIEMENS HEALTHINEERS AG | 14.72 | 43.744B | ||
| 1PHIA | KONINKLIJKE PHILIPS NV | 16.04 | 23.621B | ||
| PHIA | KONINKLIJKE PHILIPS NV | 15.97 | 23.505B | ||
| PHI1 | KONINKLIJKE PHILIPS NV | 15.96 | 23.505B | ||
| BIM | BIOMERIEUX | 19.36 | 11.25B | ||
| DIA | DIASORIN SPA | 15.72 | 3.581B | ||
| OBCK | OTTOBOCK SE & CO KGAA | 17.85 | 3.411B | ||
| 1AFX | CARL ZEISS MEDITEC AG - BR | 10.14 | 2.139B | ||
| AFX | CARL ZEISS MEDITEC AG - BR | 11.45 | 2.113B | ||
| DRW3 | DRAEGERWERK AG - PREF | 10.9 | 1.621B | ||
| DRW8 | DRAEGERWERK AG | 8.65 | 1.291B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About IX1.DE
Company Profile
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. The company is headquartered in Westbrook, Maine and currently employs 11,000 full-time employees. The firm also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.
Company Info
IPO: 1991-06-21
IDEXX LABORATORIES INC
One Idexx Drive
Westbrook MAINE US
Employees: 11000
Phone: 12075560300
IDEXX LABORATORIES INC / IX1.DE FAQ
What does IDEXX LABORATORIES INC do?
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. The company is headquartered in Westbrook, Maine and currently employs 11,000 full-time employees. The firm also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.
What is the stock price of IDEXX LABORATORIES INC today?
The current stock price of IX1.DE is 514.6 EUR. The price decreased by -8.37% in the last trading session.
Does IX1 stock pay dividends?
IX1.DE does not pay a dividend.
What is the ChartMill technical and fundamental rating of IX1 stock?
IX1.DE has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
What is the analyst forecast for IX1.DE stock?
22 analysts have analysed IX1.DE and the average price target is 692.16 EUR. This implies a price increase of 34.5% is expected in the next year compared to the current price of 514.6.
Can you provide the market cap for IDEXX LABORATORIES INC?
IDEXX LABORATORIES INC (IX1.DE) has a market capitalization of 40.97B EUR. This makes IX1.DE a Large Cap stock.
What is the next earnings date for IX1 stock?
IDEXX LABORATORIES INC (IX1.DE) will report earnings on 2026-04-29, before the market open.